Partnering to make advanced fluorescence techniques intuitive, affordable, and accessible PicoQuant GmbH has invested in FluoBrick Solutions GmbH, a Berlin-based start-up dedicated to lowering the barriers to single-molecule techniques such as Fluorescence Correlation Spectroscopy (FCS) and Förster Resonance Energy Transfer (FRET). The 2025 spin-off from LMU Munich develops ready-to-use instruments that help researchers study proteins […]
Mastermind® FLEX Data powers Compass Bioinformatics’s InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond while advancing precision medicine globally Ann Arbor, MI, USA and Tokyo, Japan – Genomenon, a leading genomic intelligence company, today announced a strategic partnership with Compass Bioinformatics, integrating Genomenon’s Mastermind FLEX Data into Compass Bioinformatic’s innovative […]
Waddinxveen (NL) — INTEGRA Biosciences Group, a leading provider of laboratory tools for liquid handling and media preparation based in Switzerland, is buying shares in CleanNA, an established reagent manufacturer based in the Netherlands. This initial investment will cement a long-term strategic collaboration between the two companies, with a view to expanding CleanNA’s global reach and […]
BioFlyte Partners with Los Alamos National Laboratory to Optimize Modeling and Simulation Tools for Biothreat Detection and Response ALBUQUERQUE, N.M. – BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, today announced a new collaboration with Los Alamos National Laboratory (LANL) as […]
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansion of tumor-agnostic CDx claims underscores Illumina’s commitment to advance access for […]
SALT LAKE CITY and BOSTON — Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the […]
ZEISS and Concept Life Sciences announce partnership Jena, Germany | ZEISS Research Microscopy Solutions — ZEISS Microscopy and Concept Life Sciences, a UK-based contract research organization (CRO), announced their collaboration aimed at pioneering new approaches to workflow automation and scalable image analysis in spatial biology. Key focus areas of the collaboration are: Automated high-throughput imaging […]
Merck KGaA and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry. Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens Xcelerator Platform and Life Science portfolio of Merck KGaA, Darmstadt, Germany Joint projects include developing AI-driven […]
MoU signed to deliver end-to-end digital workflows from drug discovery to manufacturing through combination of technology from the Siemens Xcelerator platform and Merck’s Life Sciences portfolio Joint projects include developing AI-driven tools and digital interfaces that simplify complex scientific processes Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership […]
BOSTON — SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS’s AI […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
